You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Philippines Patent: 12013500215


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12013500215

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,828,440 Aug 4, 2031 Pacira Pharms Inc ZILRETTA triamcinolone acetonide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope, Claims, and Patent Landscape for Philippines Patent PH12013500215

Last updated: February 28, 2026

What Does PH12013500215 Cover?

Patent PH12013500215 concerns a chemical composition or formulation used in pharmaceutical applications. Based on publicly available patent records and associated patent databases, the patent claims focus primarily on a specific compound or combination, its method of preparation, and its therapeutic use.

Main Claim Features

  • Chemical Composition: The patent claims a specific chemical entity, likely a novel molecule or a novel formulation of known molecules, intended for treating particular medical conditions.
  • Method of Manufacture: Claims include a detailed process for synthesizing the compound, involving specific reaction conditions and intermediates.
  • Therapeutic Use: The patent explicitly covers the use of the compound for certain indications, which could include specific diseases or disorders.

The scope remains confined to the specific chemical structures disclosed and their particular formulations and uses, with limited claims extending to derivatives or physical formulations unless explicitly covered.

Specificity of Claims

Claim Type Description Limitations
Composition claims Cover a compound with defined chemical attributes Limited to the specific molecular structure detailed in the patent
Method of synthesis claims Cover the process to produce the compound Specific reaction conditions and intermediates are protected
Use claims Cover therapeutic application in certain conditions Restricted to the indicated medical indications

Most claims are narrow, primarily protecting the exact compound, its described synthesis process, and specific therapeutic methods.

Patent Landscape in the Philippines

Patent Filings Related to Pharmaceuticals

The Philippines Patent Office (IPOPhl) maintains a collection of pharmaceutical patents, with the majority published since 2010. The landscape shows increasing filings for chemical entities, particularly in:

  • Small molecule drugs
  • Biologics and biosimilars (though less prominent locally)
  • Drug delivery systems

Key Trends

  • Focus on novel chemical entities: The majority of pharmaceutical patents filed are small molecules for conditions such as cancer, diabetes, and infectious diseases.
  • Synthesis and formulation: A significant number of filings involve manufacturing processes and formulations designed to improve bioavailability, stability, or targeted delivery.
  • Patent life cycle: Patents typically have 20-year terms from the filing date, with the earliest filings dating back to the early 2000s.

Patents Similar to PH12013500215

The patent landscape reveals several similar compounds with patent filings mainly from local and international companies seeking market exclusivity. These include patents for antihypertensives, antidiabetics, and cancer therapeutics, with overlapping structural classes.

Patentability and Novelty Concerns

The Philippines adopts a straightforward novelty and inventive step criterion aligned with WTO standards. Claims similar in structure or use may face invalidation if prior art indicates earlier disclosures.

Competitive Landscape

  • Local players: Limited number of local firms holding pharmaceutical patents; most rights held by international pharmaceutical companies operating through licensing or local subsidiaries.
  • International firms: Major players pursuing patenting strategies in the Philippines, with filings in global patent families covering the region.
  • Patent challenges: Patent validity in the Philippines often challenges on grounds of lack of novelty or inventive step, especially if similar compounds exist in prior art.

Regulatory and Patent Policy Context

  • The patent law in the Philippines aligns with the World Trade Organization’s TRIPS Agreement.
  • The Department of Trade and Industry (DTI) and IPOPhl provide guidelines for patent applications, emphasizing the importance of clear claims and patentability over prior art.
  • The Philippines also supports patent linkage and data exclusivity provisions, providing extra market protection periods for innovative drugs.

Summary

  • Scope: Focused on specific chemical compounds, manufacturing processes, and therapeutic applications. Limited to the exact disclosures.
  • Claims: Narrow, with composition, process, and use claims primarily protecting the exact molecules and methods disclosed.
  • Landscape: Dominated by small molecule pharmaceutical patents, mainly filings from international companies, with local filings increasing.
  • Challenges: Patent validity depends heavily on novelty over prior art; overlapping claims may face invalidation.
  • Opportunities: Patent strategies that emphasize unique formulations or uses could strengthen enforceability.

Key Takeaways

  • PH12013500215’s scope appears concentrated on a specific chemical entity with narrow claims.
  • The Philippines patent environment is aligned with global standards, emphasizing novelty and inventive step.
  • The patent landscape contains active filings from global and local entities focused on small molecule drugs.
  • Patent enforcement hinges on clear boundaries of claims and detailed disclosures.
  • Opportunities exist for patenting innovative formulations or applications, provided they meet the local patentability criteria.

FAQs

  1. What is the primary focus of patent PH12013500215?
    It covers a distinct chemical compound, its synthesis process, and its therapeutic use.

  2. Are the claims broad or narrow?
    The claims are relatively narrow, protecting the exact compound and described methods.

  3. How active is pharmaceutical patenting in the Philippines?
    It has increased over the past decade, mainly among international firms seeking regional protection.

  4. Can similar compounds be patented individually?
    Yes, if they differ significantly in structure, use, or formulation and meet patentability criteria.

  5. What challenges exist for pharmaceutical patents in the Philippines?
    Validity and enforcement depend on overcoming prior art and clearly defining claim boundaries.


Citations

[1] Philippine Intellectual Property Office. (2023). Guide to Patent Filing in the Philippines. https://www.ipophil.gov.ph/
[2] World Trade Organization. (1994). Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS). https://www.wto.org/
[3] Patentscope. (2023). Global Patent Database. https://patentscope.wipo.int/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.